Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at <a href='https://www.genengnews.com/'>Genetic Engineering & Biotechnology News</a> discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.

Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at Genetic Engineering & Biotechnology News discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.

Biotech and biopharma companies are in a phase of accelerated growth. Alex Philippidis, a science journalist at <a href="https://www.genengnews.com/" rel="noopener noreferrer">Genetic Engineering &amp; Biotechnology News</a> discusses the changing face of big pharma, biotech, and CRISPR gene editing industries, as they raise more money and the world changes around them.

Alex Philippidis Reviews Trends in Biopharma & Biotech Market

Welcome to the CRISPR revolution. Take a break and join us as we guide conversations with an expert CRISPR cast about this cutting-edge science.

Share Alex Philippidis Reviews Trends in Biopharma & Biotech Market

Sign up to save your podcasts

Alex Philippidis Reviews Trends in Biopharma & Biotech Market

Alex Philippidis Reviews Trends in Biopharma & Biotech Market